Public Opinion

Timely insights and analysis from KFF staff

other topics

the essentials

Health Tracking Poll

Our signature survey project provides up-to-date data on the public’s health care views, knowledge, and experiences.

Survey Question Finder

Search all KFF polls since 1992 by keyword and date to find full question wording and results.

Health Information and Trust Tracking Poll

The Health Information and Trust Tracking Poll is part of KFF’s Health Information and Trust Initiative, which tracks health misinformation and analyzes its impact on the public.

Polls in Health Policy

This chapter of our digital “textbook” explores why surveys are essential for understanding health policy issues. 

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

Filter

711 - 720 of 1,785 Results

  • GOP Views of Medicaid Expansion Differ From Conventional Wisdom

    News Release

    In his latest column for The Wall Street Journal’s Think Tank, Drew Altman examines Republican attitudes on Medicaid expansion in light of last night’s election of Republican Matt Bevin as Kentucky’s next governor. All previous columns by Drew Altman are available online.

  • Primary Care Physicians Accepting Medicare: A Snapshot

    Issue Brief

    This Data Note presents findings on reported acceptance of Medicare patients among non-pediatric primary care physicians, based on data from the Kaiser Family Foundation/Commonwealth Fund 2015 National Survey of Primary Care Providers. In addition to comparing physicians’ acceptance of Medicare to private insurance and Medicaid, this Data Note also explores the characteristics of non-pediatric primary care physicians who accept new Medicare patients and who have greater shares of Medicare patients in their caseloads.

  • The Good and Bad of Those Ubiquitous Drug Ads

    News Release

    In his latest column for The Wall Street Journal’s Think Tank, Drew Altman examines the public’s mixed views about prescription drug ads and their impact on prescribing patterns, based on a new Kaiser Family Foundation survey. All previous columns by Drew Altman are available online.

  • The Good and Bad of Those Ubiquitous Drug Ads

    From Drew Altman

    In this column for The Wall Street Journal's Think Tank, Drew Altman examines the public’s mixed views about prescription drug ads and their impact on prescribing patterns, based on a new survey.

  • Kaiser Health Tracking Poll: October 2015

    Feature

    This month’s Kaiser Health Tracking Poll finds that the affordability of prescription drugs continues to be at the top of the public’s priority list for the President and Congress, picked by majorities across political parties. Issues specific to the ACA, such as repealing provisions of the law or repealing the law entirely, fall much lower on the list. The survey also probes the public's experiences with drug advertisements. A large majority (82%) report they’ve seen or heard such advertising, and 28 percent say they have talked with a doctor about a specific drug they saw advertised. Favorable and unfavorable views of the health care law are tied this month with 42 percent favorable and 42 percent unfavorable. Few uninsured (15 percent) are aware that the third ACA enrollment period begins in November, however many (49 percent) say they expect to get health insurance in the next few months despite the fact that about half (51 percent) say they have been uninsured for 2 years or more.

  • Prescription Drug Costs Remain Atop the Public’s National Health Care Agenda, Well Ahead of Affordable Care Act Revisions and Repeal

    News Release

    28% of Public Report Asking Doctor about a Drug They Saw Advertised, and 12% Say Their Doctor Prescribed It Few Workers Expect Raises if Employers Reduce Health Benefits to Avoid Cadillac Tax as Many Economists Predict With some presidential candidates laying out details of their health care platforms, the cost of prescription drugs remains at…